Cercar

01/09/2022 Antagonism of miR-148a attenuates atherosclerosis progression in APOB(TG )Apobec(-/-)Ldlr(+/-) mice: A brief report
Rotllan, N, Zhang, XB, Canfran-Duque, A, Goedeke, L, Grinan, R, Ramirez, CM, Suarez, Y, Fernandez-Hernando, C. Antagonism of miR-148a attenuates atherosclerosis progression in APOB(TG )Apobec(-/-)Ldlr(+/-) mice: A brief report. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 153DOI:10.1016/j.biopha.2022.113419. PMID:36076541. IF:7.500(Q1/1D).
01/08/2024 Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality
Alvarado-Tapias, E, Martí-Aguado, D, Gómez-Medina, C, Ferrero-Gregori, A, Szafranska, J, Brujats, A, Osuna-Gómez, R, Guinart-Cuadra, A, Alfaro-Cervelló, C, Pose, E, Ventura-Cots, M, Clemente, A, Fernández-Carrillo, C, Contreras, C, Cabezas, J, López-Pelayo, H, Arab, J, Argemi, J, Bataller, R. Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality. Hepatology Communications. 2024; 8(8)DOI:10.1097/HC9.0000000000000490. PMID:. IF:4.600(Q1/2D).
28/02/2026 Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial)
Piedra, A, Guinart-Cuadra, A, Martínez-Recio, S, Mulet, M, Zamora, C, Osuna-Gómez, R, Cantó, E, Ortiz, MA, Alejandre, J, Barba, A, Sanz-Beltrán, J, Serra-López, J, Isla, D, Arriola, E, Paz-Ares, L, Diz-Taín, MP, Moreno, AL, Callejo, A, Vidal, S, Majem, M. Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial). Journal of Translational Medicine. 2026; 24(1)DOI:10.1186/s12967-026-07896-7. PMID:41764558. IF:7.500(Q1/2D).
01/01/2025 Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.
Buddingh, Emilie Pauline, Slatter, Mary, Becerra, Juan Carlos Aldave, Garcia, Laura Alonso, von Asmuth, Erik, Baris, Safa, de la Calle-Martin, Oscar, Chan, Alice Y, Chan, Su-Wan Bianca, Chandrakasan, Shanmuganathan, Chellapandian, Deepakbabu, Dara, Jasmeen, Farmand, Susan, Fasth, Anders, Satter, Lisa Forbes, Formankova, Renata, Grunebaum, Eyal, Keogh, Steven J, Kiykim, Ayca, Kuhl, Jorn-Sven, Laberko, Alexandra, Leahy, Timothy Ronan, Lindemans, Caroline, Martinez, Caridad, Martinez-Martinez, Laura, Mitchell, William Glenn, Morris, Emma, Oved, Joseph H, Polacik, Maria, Riviere, Jacques G, Roifman, Chaim M, Kilic, Sara Sebnem, Sedlacek, Petr, Shah, Ami J, Vong, Linda, Lankester, Arjan C, Albert, Michael H, Neven, Benedicte, Torgerson, Troy, Leiding, Jennifer, Schuetz, Catharina. Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.. Journal Of Human Immunity. 2025; 1(3)DOI:10.70962/jhi.20250027. PMID:. IF:(Q/D).
01/03/2026 Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis (vol. 7, 101611, 2025)
Rudler, M, Hernández-Gea, V, Larrue, H, Bouzbib, C, Procopet, B, Baiges, A, Turon, F, Villanueva, C, Albillos, A, Tapias, EA, Gluud, LL, Praktiknjo, M, Genesca, J, Ventura-Cots, M, Villagrasa, A, Rodrigues, S, Mouri, S, Giráldez-Gallego, A, Ridaura, HM, Laleman, W, Bureau, C, Robic, MA, Hartl, L, Tellez, L, Zipprich, A, Canete, N, Sultanik, P, Deckmyn, O, Mandorfer, M, Senzolo, M, Schepis, F, Tripathi, D, Pagan, JCG, Thabut, D. Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis (vol. 7, 101611, 2025). Jhep Reports. 2026; 8(3)DOI:10.1016/j.jhepr.2026.101750. PMID:41795962. IF:7.500(Q1/2D).
27/01/2026 Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis
Guinart-Cuadra, A, Brujats, A, Szafranska, J, Guerrero, R, Dinamarca, F, Cantó, E, Poca, M, Román, E, Sánchez-Ardid, E, Fajardo, J, Camps, M, Mulet, M, Soriano, G, Escorsell, A, Falcon-Perez, JM, Gonzalez, E, Ferrero-Gregori, A, Gely, C, Villalba, J, Bataller, R, Argemi, J, Osuna-Gómez, R, Vidal, S, Alvarado-Tapias, E. Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(3)DOI:10.3390/ijms27031258. PMID:41683683. IF:4.900(Q1/3D).
01/02/2026 Interpretable inflammation landscape of circulating immune cells
Jiménez-Gracia, L, Maspero, D, Aguilar-Fernández, S, Craighero, F, Boulougouri, M, Ruiz, M, Marchese, D, Caratù, G, Liñares-Blanco, J, Berasategi, M, Flores, ROR, Sanzo-Machuca, A, Corraliza, AM, Tran, HA, Normand, R, Nestor, J, Hong, YR, Kole, T, van der Velde, P, Alleblas, F, Pedretti, F, Aterido, A, Banchero, M, Soriano, G, Román, E, van den Berge, M, Salas, A, Carrascosa, JM, Nebro, AF, Domènech, E, Cañete, J, Tornero, J, Gisbert, JP, Choy, E, Girolomoni, G, Siegmund, B, Julià, A, Serra, V, Elosua, R, Tejpar, S, Vidal, S, Nawijn, MC, Gut, I, Saez-Rodriguez, J, Marsal, S, Villani, AC, Nieto, JC, Heyn, H. Interpretable inflammation landscape of circulating immune cells. NATURE MEDICINE. 2026; 32(2)DOI:10.1038/s41591-025-04126-3. PMID:41526507. IF:50.000(Q1/1D).
01/12/2025 Nailfold videocapillaroscopy findings correlate with lung outcomes in idiopathic inflammatory myopathies-related interstitial lung disease
Santos, CS, Tandaipan, JL, Castillo, D, Codes-Mendez, H, Martínez-Martínez, L, Magallares, B, Moya-Alvarado, P, Mariscal, A, Park, HS, Díaz-Torné, C, Fernandez-Sanchez, SP, Bernardez, J, Corominas, H, Alvarez, ED, Castellví, I. Nailfold videocapillaroscopy findings correlate with lung outcomes in idiopathic inflammatory myopathies-related interstitial lung disease. RHEUMATOLOGY. 2025; 64(SI)DOI:10.1093/rheumatology/keae669. PMID:39658251. IF:4.400(Q1/1D).
17/03/2026 Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease
Nieto, P, Klinsing, S, Caratú, G, Dettki, M, Marchese, D, Weber, KJ, Morabito, S, Lorden, P, Ruano, I, Imkeller, K, Velasco, MA, Vidal, S, Melero, JL, Euskirchen, P, Czabanka, M, Plate, KH, Harter, PN, Pascual-Reguant, A, Steinbach, JP, Heyn, H, Zeiner, PS, Nieto, JC. Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease. Cell Reports Medicine. 2026; 7(3)DOI:10.1016/j.xcrm.2026.102651. PMID:41794040. IF:10.600(Q1/1D).
01/02/2026 Chronic inflammatory burden on aortic valve disorders and atrioventricular block risk in SpA: an ambispective cohort study
Park, HS, Laiz, A, Sánchez-Vega, J, Sainz, L, Pascual, CM, Lopez-Ferrer, A, Alija, AG, Urquiza, AC, Corominas, H. Chronic inflammatory burden on aortic valve disorders and atrioventricular block risk in SpA: an ambispective cohort study. RHEUMATOLOGY. 2026; 65(2)DOI:10.1093/rheumatology/keaf560. PMID:41206060. IF:4.400(Q1/1D).
05/06/2024 Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study
Sampedro-Nuñez, M, Herrera-Martínez, AD, Ibáñez-Costa, A, Rivero-Cortés, E, Venegas, E, Robledo, M, Martínez-Hernández, R, García-Martínez, A, Gil, J, Jordà, M, López-Fernández, J, Gavilán, I, Maraver, S, Marqués-Pamies, M, Cámara, R, Fajardo-Montañana, C, Valassi, E, Dios, E, Aulinas, A, Biagetti, B, Escola, CA, Araujo-Castro, M, Blanco, C, Paz, D, Villar-Taibo, R, Alvarez, C, Gaztambide, S, Webb, SM, Castaño, L, Bernabéu, I, Picó, A, Gálvez, MA, Soto-Moreno, A, Puig-Domingo, M, Castaño, JP, Marazuela, M, Luque, RM. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024; 190(6)DOI:10.1093/ejendo/lvae045. PMID:38701338. IF:5.200(Q1/2D).
01/02/2026 Prevalence, risk factors and management of bone complications in Cushing's syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN)
Zdrojowy-Welna, A, Amaral, C, Araujo-Castro, M, Biermasz, N, Bolanowski, M, Bollerslev, J, Brue, T, Carvalho, D, Castinetti, F, Ceccato, F, Cristante, J, Dadej, D, Detomas, M, Deutschbein, T, Ferrante, E, Elenkova, A, Gil, J, Ghigo, E, Gilis-Januszewska, A, Giordano, R, Goth, M, Greaud, C, Greenman, Y, Guelho, D, Ilovayskaya, I, Kaniuka-Jakubowska, S, Kastelan, D, Kocjan, T, Komerdus, I, Krsek, M, Maiter, D, Moros, O, Kozamernik, KM, Papakokkinou, E, Reimond, G, Ragnarsson, O, Reincke, M, Sigurjonsdottir, H, Strasburger, CJ, Tabarin, A, Tóth, M, Vila, G, Zilaitiene, B, Santos, A, Webb, SM, Valassi, E. Prevalence, risk factors and management of bone complications in Cushing's syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN). ANNALES D ENDOCRINOLOGIE. 2026; 87(1)DOI:10.1016/j.ando.2026.102490. PMID:41643854. IF:2.900(Q3/6D).
01/02/2026 Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly
Biagetti, B, Marques, P, Ferrer, R, Cardoso, LM, Moreno, EV, Fajardo-Montañana, C, Gonzalez-Fernandez, L, Pena, MMP, García-Centeno, R, Lozano-Aida, C, Novoa-Testa, I, Pascual-Corrales, E, Sánchón, R, Guerrero-Pérez, F, Rodríguez, RO, Jiménez, BR, García, MDO, Echarri, AI, Simó-Servat, A, Rodríguez, MDM, Calatayud, M, Villar-Taibo, R, Tenorio-Jimenéz, C, Novo-Rodríguez, C, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, Aulinas, A, Roca, QA, Paja, M, Galiana, PA, Cordido, F, Torre, EM, Cámara, R, Sarria-Estrada, S, Rodríguez, SA, Lamas, C, Alvarez-Escola, C, Bernabéu, I, Hanzu, F, Marazuela, M, Puig-Domingo, M, Araujo-Castro, M. Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly. Endocrine Practice. 2026; 32(2)DOI:10.1016/j.eprac.2025.10.006. PMID:41101706. IF:4.600(Q1/3D).
01/04/2026 Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study
Marques-Pamies, M, Ricou, L, Gil, J, Sampedro-Núñez, M, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Torres, A, Librizzi, S, Calatayud, M, Novoa, PD, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Valassi, E, Puig-Domingo, M. Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study. Journal Of The Endocrine Society. 2026; 10(4)DOI:10.1210/jendso/bvag030. PMID:41798894. IF:(Q/D).
01/04/2026 Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain
Araujo-Castro, M, Garcia-Centeno, R, Fernández, LG, Soto-Moreno, A, Camara, R, García, MDO, Echarri, AI, Gracia, P, Pascual-Corrales, E, Biagetti, B, Cardona, A, Molero, IG, Simo-Servat, A, Guerrero-Perez, F, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Novo-Rodríguez, C, Tenorio-Jimenéz, C, Calatayud, M, Rodríguez, MDM, Cordido, F, Castro, A, Valero, LM, Paja, M, Goi, J, Aulinas, A, Abellán, P, Iglesias, P, Hanzu, FA. Efficacy and safety of osilodrostat in patients with ectopic Cushings syndrome. a real-world study in Spain. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2026; 49(4)DOI:10.1007/s40618-025-02769-0. PMID:41335191. IF:3.500(Q2/4D).
01/03/2026 Central hypothyroidism and cardiovascular disease: a Spanish cohort observational study
Guerrero-Pérez, F, Iglesias, P, Fano, MP, Rodríguez, MDM, Biagetti, B, Cordido, F, Novoa-Testa, I, García-Centeno, R, Fernández, LG, Araujo-Castro, M, Villar-Taibo, R, García, L, Fernández-Rodríguez, E, Capristán-Díaz, V, Simó-Servat, A, Aulinas, A, Asla, Q, Tenorio-Jiménez, C, Díez, JJ. Central hypothyroidism and cardiovascular disease: a Spanish cohort observational study. Hormones-International Journal of Endocrinology and Metabolism. 2026; 25(1)DOI:10.1007/s42000-025-00707-6. PMID:40824516. IF:2.500(Q3/7D).
01/01/2026 Recurrent pituitary apoplexy: experience from a national registry and review of the literature
Biagetti, B, Asanza, EC, Iglesias, P, Camara, R, Asla, Q, Vicente, A, Martinez-Saez, E, Sarria-Estrada, S, Puig-Domingo, M, Araujo-Castro, M. Recurrent pituitary apoplexy: experience from a national registry and review of the literature. Therapeutic Advances in Endocrinology and Metabolism. 2026; 17DOI:10.1177/20420188261434641. PMID:41919183. IF:4.600(Q1/3D).
10/03/2026 Identification of intranasal oxytocin plasma proteome signatures
Breithaupt, L, Harshman, SG, Botros, PM, Zhang, Z, Holman, K, Boutin, R, Galbiati, F, Maso, AA, Lo, JE, Soukas, A, Sadreyev, RI, Mccormack, SE, Lawson, EA. Identification of intranasal oxytocin plasma proteome signatures. ENDOCRINE. 2026; 91(1)DOI:10.1007/s12020-025-04529-9. PMID:41806102. IF:2.900(Q3/6D).
01/01/2024 Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Calafat, M, Torres, P, Tosca-Cuquerella, J, Sánchez-Aldehuelo, R, Rivero, M, Iborra, M, González-Vivo, M, Vera, I, de Castro, L, Bujanda, L, Barreiro-de Acosta, M, González-Muñoza, C, Calvet, X, Benítez, JM, Llorente-Barrio, M, Surís, G, Cañete, F, Arias-García, L, Monfort, D, Castaño-García, A, Garcia-Alonso, FJ, Huguet, JM, Marín-Jímenez, I, Lorente, R, Martín-Cardona, A, Ferrer, JA, Camo, P, Gisbert, JP, Pajares, R, Gomollón, F, Castro-Poceiro, J, Morales-Alvarado, J, Llaó, J, Rodríguez, A, Rodríguez, C, Pérez-Galindo, P, Navarro, M, Jiménez-García, N, Carrillo-Palau, M, Blázquez-Gómez, I, Sesé, E, Almela, P, de la Piscina, PR, Taxonera, C, Rodríguez-Lago, I, Cabrinety, L, Vela, M, Mínguez, M, Mesonero, F, García, MJ, Aguas, M, Márquez, L, Porto, MS, Pineda, JR, García-Etxebarría, K, Bertoletti, F, Brunet, E, Mañosa, M, Domènech, E. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry. Therapeutic Advances in Gastroenterology. 2024; 17DOI:10.1177/17562848231221713. PMID:38187926. IF:3.400(Q2/4D).
01/01/2024 Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries
Medina-Cáliz, I, Sanabria-Cabrera, J, Villanueva-Paz, M, Aukstikalne, L, Stephens, C, Robles-Díaz, M, Pinazo-Bandera, JM, García-Cortes, M, Conde, I, Soriano, G, Bessone, F, Hernandez, N, Nunes, V, Paraná, R, Lucena, MI, Andrade, RJ, Niu, H, Alvarez-Alvarez, I. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries. ARCHIVES OF TOXICOLOGY. 2024; 98(1)DOI:10.1007/s00204-023-03630-0. PMID:38051367. IF:6.900(Q1/1D).